AF
VERA icon

Amalgamated Financial’s Vera Therapeutics VERA Stock Holding History

Amalgamated Financial’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$34K Buy
+1,438
New +$30.9K ﹤0.01% 2582

Other funds holding VERA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Amalgamated Financial's VERA Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Vera Therapeutics (VERA) in Q1 2022: 1,438 shares worth $34K. The stake represents ﹤0.01% of the portfolio and ranks #2582 among its holdings.

50 funds tracked by Wall St. Rank hold VERA as of Q1 2022.

  • Amalgamated Financial held 1,438 shares of Vera Therapeutics worth $34K as of Q1 2022.
  • Vera Therapeutics was a new Amalgamated Financial position in Q1 2022.
  • Vera Therapeutics made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2582 holding.
  • 50 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.